Zika virus secondary prevention: Difference between revisions

Jump to navigation Jump to search
(Category)
m (Bot: Removing from Primary care)
 
Line 28: Line 28:
{{reflist|2}}
{{reflist|2}}
{{WH}}{{WS}}
{{WH}}{{WS}}
[[Category:Emergency mdicine]]
 
[[Category:Emergency mdicine]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Primary care]]
[[Category:Up-To-Date]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]

Latest revision as of 00:47, 30 July 2020

Sexually transmitted diseases Main Page

Zika virus infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Classification

Differentiating Zika Virus Infection from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Evaluation of Pregnant Women

Evaluation of Infants

Collection and Submission of Fetal Tissues

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Guidelines for Pregnant Women
Travel Notice
Blood Donation
Sexual transmission

Secondary Prevention

CDC Response Planning Tips

Risk-based Preparedness for States

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Zika virus secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Zika virus secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Zika virus secondary prevention

CDC on Zika virus secondary prevention

Zika virus secondary prevention in the news

Blogs on Zika virus secondary prevention

Directions to Hospitals Treating Zika virus infection

Risk calculators and risk factors for Zika virus secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[2]

Overview

Secondary prevention for Zika-infected patients involves efforts to reduce incidence of the most serious complication of vertical transmission and subsequent birth defects. Methods of secondary prevention of Zika virus include reduction of partner-to-partner sexual transmission, as well as appropriate family planning in endemic regions.

Secondary Prevention

Secondary prevention for Zika-infected patients involves efforts to reduce incidence of the most serious complication of vertical transmission and subsequent birth defects. Methods of secondary prevention of Zika virus include reduction of partner-to-partner sexual transmission, as well as appropriate family planning in endemic regions. The following is a CDC-recommended guideline for infected Zika patients planning a pregnancy:[1]

How Long to Wait Before Attempting to Have a Baby in Zika Endemic areas
Presence of Symptoms Women Men
Zika symptoms At least 8 weeks after symptoms start At least 6 months after symptoms start
No Zika symptoms Talk with doctor or healthcare provider Talk with doctor or healthcare provider

References

  1. CDC Zika Virus Guideline. Accessed on October 4th, 2016.

Template:WHTemplate:WS